Description
JH-II-127 is a selective inhibitor of leucine-rich repeat kinase 2 (LRRK2), a potential therapeutic target for neurodegenerative disease. It inhibits phosphorylation of Ser910 and Ser935 in both wild-type LRRK2 and the G2019S mutant.
Product Unit Size | Cost | Quantity | Stock |
---|
JH-II-127 is a selective inhibitor of leucine-rich repeat kinase 2 (LRRK2), a potential therapeutic target for neurodegenerative disease. It inhibits phosphorylation of Ser910 and Ser935 in both wild-type LRRK2 and the G2019S mutant.
Cas No. | 1700693-08-8 |
---|---|
Purity | ≥98% |
Formula | C19H21ClN6O3 |
Formula Wt. | 416.87 |
IUPAC Name | (4-{[5-Chloro-4-(methylamino)-3H-pyrrolo[2,3-d]pyrimidin-2-yl]amino}-3-methoxyphenyl)(4-morpholinyl)methanone |
Synonym | Pyrrolopyrimidine |
Solubility | DMSO |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Hatcher J., Zhang J., et al. Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 Inhibitor. ACS Med Chem Lett. 6(5):584-9 (2015). PMID: 26005538.
α-glucosidase inhibitor.
NDRI inhibitor
Peptide, derivative of AT II, involved in vasoc...
Nucleoside (deoxyguanosine) analog; DNA chain t...
Folic acid derivative
SIRT inhibitor.
Endogenous peptide hormone, GLP-1 fragment, inv...
GPR17 agonist, NMDA and fructose 1,6-bisphospha...
Nucleoside (guanosine) analog; RT, guanylyl cyc...
Tetrapeptide, binds cell surface integrins.
Antimicrobial peptide found in bee and wasp ven...
Immunodominant peptide epitope occurring in mul...
BRD2/3/4 inhibitor.
Cdc7 inhibitor.
NO donor.
Antimicrobial peptide, generated during fibrin ...
Synthesis intermediate
Mycotoxin produced by Aspergillus; actin polyme...
Fluoroquinolone, S-(-) isomer of ofloxacin; top...
Polyphenolic compound present in black tea.